Skip to content

Cardinal Health

NYSE: CAH · USD

Cardinal Health revenue93

Quarterly and annual revenue from company filings.

Business drivers

Business lines and operating measures.

Pharmaceutical and Specialty Solutions · Operating Segments revenue

Reported annual Pharmaceutical and Specialty Solutions · Operating Segments revenue. Annual figures · USD

Pharmaceutical and Specialty Solutions · Operating Segments revenue. Reported annual Pharmaceutical and Specialty Solutions · Operating Segments revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jun 30, 2026From Jul 1, 2025234,833,000,000Filed Aug 11, 2026
Jun 30, 2025From Jul 1, 2024204,644,000,000Filed Aug 11, 2026
Jun 30, 2024From Jul 1, 2023210,019,000,000Filed Aug 11, 2026

Global Medical Products and Distribution · Operating Segments revenue

Reported annual Global Medical Products and Distribution · Operating Segments revenue. Annual figures · USD

Global Medical Products and Distribution · Operating Segments revenue. Reported annual Global Medical Products and Distribution · Operating Segments revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jun 30, 2026From Jul 1, 202512,719,000,000Filed Aug 11, 2026
Jun 30, 2025From Jul 1, 202412,636,000,000Filed Aug 11, 2026
Jun 30, 2024From Jul 1, 202312,381,000,000Filed Aug 11, 2026

at-Home Solutions · Operating Segments revenue

Reported annual at-Home Solutions · Operating Segments revenue. Annual figures · USD

at-Home Solutions · Operating Segments revenue. Reported annual at-Home Solutions · Operating Segments revenue. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jun 30, 2026From Jul 1, 20254,536,000,000Filed Aug 11, 2026
Jun 30, 2025From Jul 1, 20243,480,000,000Filed Aug 11, 2026
Jun 30, 2024From Jul 1, 20232,869,000,000Filed Aug 11, 2026

Independent series; they may overlap and do not form an additive breakdown.

  • Available proposals measure business-line revenue rather than operating volumes.

Products & projects

Revenue history

USD millions · Fiscal periods
Sep 30, 2009 through Jun 30, 2026

Quarterly data

Cardinal Health quarterly financial data in USD millions. FY denotes the company's fiscal year. YTD covers reported quarters only.
Fiscal quarterEndedTotal revenueUSD millions
FY 2026 Q4Jun 30, 202663,672, +4.5% versus FY 2026 Q3
FY 2026 Q3Mar 31, 202660,940, −7.1% versus FY 2026 Q2
FY 2026 Q2Dec 31, 202565,627, +2.5% versus FY 2026 Q1
FY 2026 Q1Sep 30, 202564,009, +6.4% versus FY 2025 Q4
FY 2025 Q4Jun 30, 202560,159, +9.6% versus FY 2025 Q3
FY 2025 Q3Mar 31, 202554,878, −0.7% versus FY 2025 Q2
FY 2025 Q2Dec 31, 202455,264, +5.7% versus FY 2025 Q1
FY 2025 Q1Sep 30, 202452,277, −12.4% versus FY 2024 Q4
FY 2024 Q4Jun 30, 202459,708, +8.7% versus FY 2024 Q3
FY 2024 Q3Mar 31, 202454,911, −4.4% versus FY 2024 Q2
FY 2024 Q2Dec 31, 202357,445, +4.9% versus FY 2024 Q1
FY 2024 Q1Sep 30, 202354,763, +2.5% versus FY 2023 Q4
FY 2023 Q4Jun 30, 202353,453, +5.9% versus FY 2023 Q3
FY 2023 Q3Mar 31, 202350,487, −1.9% versus FY 2023 Q2
FY 2023 Q2Dec 31, 202251,469, +3.8% versus FY 2023 Q1
FY 2023 Q1Sep 30, 202249,603, +5.3% versus FY 2022 Q4
FY 2022 Q4Jun 30, 202247,103, +5.1% versus FY 2022 Q3
FY 2022 Q3Mar 31, 202244,836, −1.4% versus FY 2022 Q2
FY 2022 Q2Dec 31, 202145,457, +3.4% versus FY 2022 Q1
FY 2022 Q1Sep 30, 202143,968, +3.2% versus FY 2021 Q4
FY 2021 Q4Jun 30, 202142,586, +8.4% versus FY 2021 Q3
FY 2021 Q3Mar 31, 202139,275, −5.5% versus FY 2021 Q2
FY 2021 Q2Dec 31, 202041,541, +6.3% versus FY 2021 Q1
FY 2021 Q1Sep 30, 202039,065, +6.5% versus FY 2020 Q4
FY 2020 Q4Jun 30, 202036,689, −6.3% versus FY 2020 Q3
FY 2020 Q3Mar 31, 202039,157, −1.5% versus FY 2020 Q2
FY 2020 Q2Dec 31, 201939,735, +6.4% versus FY 2020 Q1
FY 2020 Q1Sep 30, 201937,341, 0.0% versus FY 2019 Q4
FY 2019 Q4Jun 30, 201937,353, +6.0% versus FY 2019 Q3
FY 2019 Q3Mar 31, 201935,228, −6.7% versus FY 2019 Q2
FY 2019 Q2Dec 31, 201837,740, +7.2% versus FY 2019 Q1
FY 2019 Q1Sep 30, 201835,213, −0.4% versus FY 2018 Q4
FY 2018 Q4Jun 30, 201835,349, +5.1% versus FY 2018 Q3
FY 2018 Q3Mar 31, 201833,633, −4.4% versus FY 2018 Q2
FY 2018 Q2Dec 31, 201735,186, +7.8% versus FY 2018 Q1
FY 2018 Q1Sep 30, 201732,641, −1.0% versus FY 2017 Q4
FY 2017 Q4Jun 30, 201732,966, +3.6% versus FY 2017 Q3
FY 2017 Q3Mar 31, 201731,821, −4.0% versus FY 2017 Q2
FY 2017 Q2Dec 31, 201633,150, +3.5% versus FY 2017 Q1
FY 2017 Q1Sep 30, 201632,039, +2.1% versus FY 2016 Q4
FY 2016 Q4Jun 30, 201631,384, +2.4% versus FY 2016 Q3
FY 2016 Q3Mar 31, 201630,662, −2.5% versus FY 2016 Q2
FY 2016 Q2Dec 31, 201531,445, +12.1% versus FY 2016 Q1
FY 2016 Q1Sep 30, 201528,055, +1.8% versus FY 2015 Q4
FY 2015 Q4Jun 30, 201527,547, +8.6% versus FY 2015 Q3
FY 2015 Q3Mar 31, 201525,375, −0.6% versus FY 2015 Q2
FY 2015 Q2Dec 31, 201425,537, +6.1% versus FY 2015 Q1
FY 2015 Q1Sep 30, 201424,070, +5.1% versus FY 2014 Q4
FY 2014 Q4Jun 30, 201422,894, +6.8% versus FY 2014 Q3
FY 2014 Q3Mar 31, 201421,427, −3.7% versus FY 2014 Q2
FY 2014 Q2Dec 31, 201322,240, −9.3% versus FY 2014 Q1
FY 2014 Q1Sep 30, 201324,523, −3.5% versus FY 2013 Q4
FY 2013 Q4Jun 30, 201325,420, +3.5% versus FY 2013 Q3
FY 2013 Q3Mar 31, 201324,552, −2.7% versus FY 2013 Q2
FY 2013 Q2Dec 31, 201225,232, −2.5% versus FY 2013 Q1
FY 2013 Q1Sep 30, 201225,889, −3.3% versus FY 2012 Q4
FY 2012 Q4Jun 30, 201226,764, −0.6% versus FY 2012 Q3
FY 2012 Q3Mar 31, 201226,917.5, −0.6% versus FY 2012 Q2
FY 2012 Q2Dec 31, 201127,078, +1.1% versus FY 2012 Q1
FY 2012 Q1Sep 30, 201126,792, +0.1% versus FY 2011 Q4
FY 2011 Q4Jun 30, 201126,763.5, +2.7% versus FY 2011 Q3
FY 2011 Q3Mar 31, 201126,071.4, +2.8% versus FY 2011 Q2
FY 2011 Q2Dec 31, 201025,371.8, +3.8% versus FY 2011 Q1
FY 2011 Q1Sep 30, 201024,437.5, −0.1% versus FY 2010 Q4
FY 2010 Q4Jun 30, 201024,459.6, +0.5% versus FY 2010 Q3
FY 2010 Q3Mar 31, 201024,342.8, −2.3% versus FY 2010 Q2
FY 2010 Q2Dec 31, 200924,919.7, +0.6% versus FY 2010 Q1
FY 2010 Q1Sep 30, 200924,780.7, Change unavailable versus FY 2009 Q4
Sources and definitions

Figures from official company filings and financial reports, in the reported currency. FY identifies the fiscal year; the end date identifies the calendar period. Last checked Oct 19, 2026.

Annual values come from annual filings. Historical quarters retain their reporting basis; rounding and reclassifications can make their sum differ from the annual figure. YTD sums the available fiscal quarters and compares the same quarters of the previous fiscal year.

Missing values are shown as unavailable. Fourth quarters use reported values where available, otherwise the annual amount less the matching nine-month amount.

Total revenue
Reported consolidated revenue from the issuer filing. Each observation identifies its accounting concept; bank net revenue is net of interest expense when that concept is reported.
Annual and quarterly differences
  • FY 2012 · Total revenue: annual 107,552, quarter sum 107,551.5 USD millions.
  • FY 2015 · Total revenue: annual 102,531, quarter sum 102,529 USD millions.